알파 코그니션 (ACOG) 주가

알파 코그니션(ACOG)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $8.86 (+0.11%), 시가총액 $0.13B, 52주 최저~최고 $4.50 ~ $11.24.

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, includin

핵심 지표

• 현재가: $8.86 (+0.11%)
• 시가총액: $0.13B
• 52주 최저~최고: $4.50 ~ $11.24
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NASDAQ

알파 코그니션의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

알파 코그니션 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 2.16
• 순이익률: -2.35%
• 영업이익률: -2.29%

자주 묻는 질문